This multicenter , double-blind , placebo-controlled , repeat treatment , @-month study randomized subjects with moderate-to-severe CFL and GL ( maximum contraction ) to onabotulinumtoxinA @ U ( CFL : @ U , GL : @ U ; n = @ ) , onabotulinumtoxinA @ U ( CFL : @ U , GL : placebo ; n = @ ) , or placebo ( n = @ ) .